Junping Shi
5PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 28, 2020
Mutational Characterization and Potential Prognostic Biomarkers of Chinese Patients with Esophageal Squamous Cell Carcinoma.Nan Zhang, Junping Shi, Xiaoliang Shi
|May 06, 2020
Significant Benefits of Osimertinib Against Adenosquamous Carcinoma Harboring Germline T790M Mutation.Ran Huo, Jinghua Li, Xiaofang Li
|Feb 27, 2020
Efficacy of Cabozantinib and Nivolumab in Treating Hepatocellular Carcinoma with RET Amplification, High Tumor Mutational Burden, and PD-L1 Expression.Xiaobo Yang, Junping Shi, Xiaoqian Chen
|Feb 12, 2020
Effectiveness of Olaparib Treatment in a Patient with Gallbladder Cancer with an ATM-Inactivating Mutation.Wei Zhang, Junping Shi, Rentao Li
|May 09, 2019
Effectiveness of EGFR-TKIs in a Patient with Lung Adenocarcinoma Harboring an EGFR-RAD51 Fusion.Yan Guan, Zhanshuai Song, Yan Li
Pageof 1
Frequent Collaborators
1 joint publications
Honglin Guo
1 joint publications
Ming Yao
1 joint publications
Wei Zhang
1 joint publications
Zhiqiang Han
1 joint publications
Guanghao Li
1 joint publications
Bo Yang
1 joint publications
Qiang Yin
1 joint publications
Yingying Wang
1 joint publications
Xiaoqian Chen
1 joint publications
Haitao Zhao
